Understand your health. Know what to ask.
Sleep changes after starting a GLP-1: what to pay attention to
Digestive symptoms, fatigue and an existing sleep problem can overlap. Describe the change in sleep rather than assuming one cause.
3 sources · NIHRead · 2 min →
Heartburn during GLP-1 treatment: what to report
Reflux can occur during semaglutide treatment. The timing, severity and accompanying symptoms help a provider assess what is happening.
2 sources · NIHRead · 2 min →
GLP-1 constipation: food, fluids and bowel function
Constipation during GLP-1 treatment can have several contributors. Stool consistency, intake, medicines and warning symptoms all matter.
4 sources · NIHRead · 2 min →
Can fasting insulin explain a weight-loss plateau?
A fasting insulin result cannot decide whether a medication should change. Learn what glucose tests and a treatment review can clarify.
2 sources · NIHRead · 2 min →
Perimenopause and metabolic health: which numbers add useful context?
Glucose, blood pressure and cholesterol answer different questions when body composition changes in midlife.
4 sources · NIH, PubMed / PMCRead · 2 min →
Why weight loss can slow during GLP-1 treatment
A smaller body generally needs less energy. A plateau review considers the weight trend, nutrition, activity and treatment response together.
2 sources · NIHRead · 2 min →
Persistent nausea on a GLP-1: when to contact the prescriber
Nausea is a recognized side effect, but symptoms that persist, worsen or interfere with fluids deserve a review. Know which symptoms need urgent care.
2 sources · NIH, PubMed / PMCRead · 2 min →
GLP-1 medicines and birth control: the tirzepatide distinction
Tirzepatide can reduce oral hormonal contraceptive effectiveness. Learn what its label says and why this should not be generalized to every GLP-1.
3 sources · NIHRead · 2 min →
A post-vacation weight increase during GLP-1 maintenance
A short-term scale change can include water and other mass, not just fat. The pattern over time is more informative than one post-travel reading.
6 sources · PubMed / PMC, NIHRead · 2 min →
Fasting insulin and HOMA-IR: what the numbers can tell you
HOMA-IR estimates insulin resistance from fasting glucose and insulin. Learn what it measures and how it differs from diabetes testing.
4 sources · PubMed / PMC, NIHRead · 2 min →
Strength training during GLP-1 treatment: what to keep track of
Weight is one measure. Strength, adequate nutrition and the ability to recover also belong in a GLP-1 treatment review.
3 sources · NIHRead · 2 min →
Loose skin after weight loss: realistic expectations
Skin may not fully adapt after substantial weight loss. Muscle preservation and treatment pacing matter, but they do not guarantee skin tightening.
5 sources · NIH, PubMed / PMCRead · 2 min →